Standard BioTools
LAB
LAB
72 hedge funds and large institutions have $138M invested in Standard BioTools in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 19 reducing their positions, and 9 closing their positions.
Holders
72
Holders Change
+6
Holders Change %
+9.09%
% of All Funds
1.15%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
16
Reduced
19
Closed
9
Calls
$83K
Puts
$99K
Net Calls
-$16K
Net Calls Change
+$17K
Top Buyers
Top Sellers
| 1 |
BFM
1
Boothbay Fund Management
New York
|
$3.5M |
| 2 |
CP
2
Caligan Partners
New York
|
$22.1M |
| 3 |
NIM
3
Needham Investment Management
New York
|
$3.55M |
| 4 |
4
HighTower Advisors
Chicago,
Illinois
|
$559K |
| 5 |
5
D.E. Shaw & Co
New York
|
$419K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Walleye Capital
New York
| – | -$39.6K | -20,535 | Closed |
|
77
Cerity Partners
New York
| – | -$24.3K | -12,588 | Closed |
|
|
HF
78
HRT Financial
New York
| – | -$22K | -11,877 | Closed |
|
|
FHA
79
First Horizon Advisors
Memphis,
Tennessee
| – | -$5.79K | -3,000 | Closed |
|
|
RP
80
Repertoire Partners
New York
| – | -$193 | -100 | Closed |
|